So, the natural question for Bionomics (ASX:BNO) shareholders is whether they should be concerned by its rate of cash burn. In this report, we will consider the company's annual negative free cash ...

ADELAIDE, Australia and CAMBRIDGE, Mass., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel ...

Solid formulation of BNC210 better and faster administration than liquid formulation. Bionomics PTSD Phase 2b trial will start soon with a tablet formulation. BNC210 has previously shown benefit ...

I FOLLOW Prof. Lankester in the use of bionomics to designate the science treating of the relations of species to species. If the theory of evolution is true, bionomics should treat of the origin ...

Bionomics Limited (NASDAQ: BNOX) has recently secured a significant private placement that could inject up to $70 million into the company, contingent on reaching key milestones. As investors ...

Neuphoria Therapeutics Inc. has completed its redomiciliation, transferring governance from Bionomics’ organizational documents to Neuphoria’s new Certificate of Incorporation and bylaws.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Bionomics is progressing BNC-210 to phase III trials in post-traumatic stress disorder (PTSD) following positive feedback from the U.S. FDA. Final data from the phase II Attune study were presented at ...

Bionomics’ bid to bounce back from its stock-crushing anxiety trial failure has finally gained some momentum, with investors sending the share price up almost 200% on the strength of phase 2 ...

Bionomics secures $70 million in private placement Open in App Get 50% Off Sign In Free Sign Up ...